3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
3
Neoplasms
2
Colonic Neoplasms
2
Adenomatous Polyposis Coli
2
Adenoma
2
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Overweight
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hepatoblastoma
1
Hepatitis
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Chemical and Drug Induced Liver Injury
1
Interventions
Colonoscopy
7
Endoscopy
3
Narrow Band Imaging
2
Eicosapentaenoic Acid
2
eicosapentaenoic acid ethyl ester
1
Uterine Myomectomy
1
Ursodeoxycholic Acid
1
Telemedicine
1
Suppositories
1
Sennosides
1
Selenium
1
Restraint, Physical
1
Radiotherapy
1
Propofol
1
Polyethylene Glycols
1
Ofloxacin
1
Midazolam
1
Metoclopramide
1
Methods
1
Folic Acid
1
Fentanyl
1
Fatty Acids, Omega-3
1
Everolimus
1
Erythromycin
1
Endoscopic Mucosal Resection
1
Endomet
1
Doxycycline
1
Docosahexaenoic Acids
1
Diet, Fat-Restricted
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polyps
×
Ursodeoxycholic Acid
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled